Review



ha gsk3 beta wt pcdna3  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Addgene inc ha gsk3 beta wt pcdna3
    PKC regulates peroxisome – ER VAP-dependent interaction through GSK3b inhibition. (A) Quantification of confocal microscopy of peroxisomes stained with anti-PMP70 antibody in WT and VAPB/VAPA KO HeLa cells in control and GFP-VAPB overexpression conditions. Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100 cells pooled from three biological repeats, ***P < 0.001, ****P < 0.0001, Kruskal–Wallis test. (B) Confocal microscopy of peroxisomes stained with anti-PMP70 antibody in WT and VAPB/VAPA KO HeLa cells in control Go6983 (5 μM for 48 h). Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100, ***P < 0.001, ****P < 0.0001, one-way ANOVA. Western blot confirming the KO is shown. (C) Co-immunoprecipitation of mycACBD5 in control and PKC inhibition conditions (Go6983 5 μM, 24 h); mycACBD5 and GFP or GFP-VAPB were overexpressed in HEK293T cells. Quantification shows the IP to input ratio, mean ± SEM, N = 3, ***P < 0.001, ****P < 0.0001, one-way ANOVA. (D–F) Live cell confocal microscopy of ER and peroxisomes in U2OS cells in control and Go6983 conditions. Quantification shows the ratio of peroxisomes that are not proximal or overlapping with the ER, mean ± SEM, N = 6 pooled from 1,000 peroxisomes in at least 30 cells per condition, **P < 0.01, and a distance traveled by a single peroxisome in 30 s, mean ± SEM, N = 1,000, ****P < 0.0001, unpaired t test with Welch’s correction. (G) Co-immunoprecipitation of GFP-VAPB in control and PKCD-mCherry overexpression conditions in HEK293T cells overexpressing mycACBD5 and GFP-VAPB. Quantification shows the IP to input ratio, mean ± SEM, N = 4, ***P < 0.001, ****P < 0.0001, unpaired t test. (H) Western blot of GSK3β inhibitory S9 phosphorylation in PMA(0.5 μM for 2 h) and Go6983 (5 μM for 4 h) conditions. Quantification shows the ratio of phosphorylated pS9 GSK3β to non-phosphorylated GSK3β, mean ± SEM, N = 4, ***P < 0.001, **P < 0.01, one-way ANOVA. (I) Confocal microscopy of peroxisomes stained with anti-PMP70 antibody in HEK293T control or overexpression of GSK3β S9A mutant in control or PMA (0.5 μM for 4 h) conditions. (I) Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100 pooled from three biological repeats, ****P < 0.0001, Welch ANOVA. (J) Model of PKC regulation of peroxisome– ER interaction. Source data are available for this figure:  . OE, overexpressing; ns, nonsignificant; coIP, co-immunoprecipitation.
    Ha Gsk3 Beta Wt Pcdna3, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ha gsk3 beta wt pcdna3/product/Addgene inc
    Average 90 stars, based on 1 article reviews
    ha gsk3 beta wt pcdna3 - by Bioz Stars, 2026-04
    90/100 stars

    Images

    1) Product Images from "Protein Kinase C promotes peroxisome biogenesis and peroxisome–endoplasmic reticulum interaction"

    Article Title: Protein Kinase C promotes peroxisome biogenesis and peroxisome–endoplasmic reticulum interaction

    Journal: The Journal of Cell Biology

    doi: 10.1083/jcb.202505040

    PKC regulates peroxisome – ER VAP-dependent interaction through GSK3b inhibition. (A) Quantification of confocal microscopy of peroxisomes stained with anti-PMP70 antibody in WT and VAPB/VAPA KO HeLa cells in control and GFP-VAPB overexpression conditions. Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100 cells pooled from three biological repeats, ***P < 0.001, ****P < 0.0001, Kruskal–Wallis test. (B) Confocal microscopy of peroxisomes stained with anti-PMP70 antibody in WT and VAPB/VAPA KO HeLa cells in control Go6983 (5 μM for 48 h). Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100, ***P < 0.001, ****P < 0.0001, one-way ANOVA. Western blot confirming the KO is shown. (C) Co-immunoprecipitation of mycACBD5 in control and PKC inhibition conditions (Go6983 5 μM, 24 h); mycACBD5 and GFP or GFP-VAPB were overexpressed in HEK293T cells. Quantification shows the IP to input ratio, mean ± SEM, N = 3, ***P < 0.001, ****P < 0.0001, one-way ANOVA. (D–F) Live cell confocal microscopy of ER and peroxisomes in U2OS cells in control and Go6983 conditions. Quantification shows the ratio of peroxisomes that are not proximal or overlapping with the ER, mean ± SEM, N = 6 pooled from 1,000 peroxisomes in at least 30 cells per condition, **P < 0.01, and a distance traveled by a single peroxisome in 30 s, mean ± SEM, N = 1,000, ****P < 0.0001, unpaired t test with Welch’s correction. (G) Co-immunoprecipitation of GFP-VAPB in control and PKCD-mCherry overexpression conditions in HEK293T cells overexpressing mycACBD5 and GFP-VAPB. Quantification shows the IP to input ratio, mean ± SEM, N = 4, ***P < 0.001, ****P < 0.0001, unpaired t test. (H) Western blot of GSK3β inhibitory S9 phosphorylation in PMA(0.5 μM for 2 h) and Go6983 (5 μM for 4 h) conditions. Quantification shows the ratio of phosphorylated pS9 GSK3β to non-phosphorylated GSK3β, mean ± SEM, N = 4, ***P < 0.001, **P < 0.01, one-way ANOVA. (I) Confocal microscopy of peroxisomes stained with anti-PMP70 antibody in HEK293T control or overexpression of GSK3β S9A mutant in control or PMA (0.5 μM for 4 h) conditions. (I) Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100 pooled from three biological repeats, ****P < 0.0001, Welch ANOVA. (J) Model of PKC regulation of peroxisome– ER interaction. Source data are available for this figure:  . OE, overexpressing; ns, nonsignificant; coIP, co-immunoprecipitation.
    Figure Legend Snippet: PKC regulates peroxisome – ER VAP-dependent interaction through GSK3b inhibition. (A) Quantification of confocal microscopy of peroxisomes stained with anti-PMP70 antibody in WT and VAPB/VAPA KO HeLa cells in control and GFP-VAPB overexpression conditions. Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100 cells pooled from three biological repeats, ***P < 0.001, ****P < 0.0001, Kruskal–Wallis test. (B) Confocal microscopy of peroxisomes stained with anti-PMP70 antibody in WT and VAPB/VAPA KO HeLa cells in control Go6983 (5 μM for 48 h). Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100, ***P < 0.001, ****P < 0.0001, one-way ANOVA. Western blot confirming the KO is shown. (C) Co-immunoprecipitation of mycACBD5 in control and PKC inhibition conditions (Go6983 5 μM, 24 h); mycACBD5 and GFP or GFP-VAPB were overexpressed in HEK293T cells. Quantification shows the IP to input ratio, mean ± SEM, N = 3, ***P < 0.001, ****P < 0.0001, one-way ANOVA. (D–F) Live cell confocal microscopy of ER and peroxisomes in U2OS cells in control and Go6983 conditions. Quantification shows the ratio of peroxisomes that are not proximal or overlapping with the ER, mean ± SEM, N = 6 pooled from 1,000 peroxisomes in at least 30 cells per condition, **P < 0.01, and a distance traveled by a single peroxisome in 30 s, mean ± SEM, N = 1,000, ****P < 0.0001, unpaired t test with Welch’s correction. (G) Co-immunoprecipitation of GFP-VAPB in control and PKCD-mCherry overexpression conditions in HEK293T cells overexpressing mycACBD5 and GFP-VAPB. Quantification shows the IP to input ratio, mean ± SEM, N = 4, ***P < 0.001, ****P < 0.0001, unpaired t test. (H) Western blot of GSK3β inhibitory S9 phosphorylation in PMA(0.5 μM for 2 h) and Go6983 (5 μM for 4 h) conditions. Quantification shows the ratio of phosphorylated pS9 GSK3β to non-phosphorylated GSK3β, mean ± SEM, N = 4, ***P < 0.001, **P < 0.01, one-way ANOVA. (I) Confocal microscopy of peroxisomes stained with anti-PMP70 antibody in HEK293T control or overexpression of GSK3β S9A mutant in control or PMA (0.5 μM for 4 h) conditions. (I) Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100 pooled from three biological repeats, ****P < 0.0001, Welch ANOVA. (J) Model of PKC regulation of peroxisome– ER interaction. Source data are available for this figure: . OE, overexpressing; ns, nonsignificant; coIP, co-immunoprecipitation.

    Techniques Used: Inhibition, Confocal Microscopy, Staining, Control, Over Expression, Western Blot, Immunoprecipitation, Phospho-proteomics, Mutagenesis



    Similar Products

    94
    Sino Biological pcdna3 1 expression vector
    Pcdna3 1 Expression Vector, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pcdna3 1 expression vector/product/Sino Biological
    Average 94 stars, based on 1 article reviews
    pcdna3 1 expression vector - by Bioz Stars, 2026-04
    94/100 stars
      Buy from Supplier

    94
    Genecopoeia pcdna3 ha ikaros mutants
    Pcdna3 Ha Ikaros Mutants, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pcdna3 ha ikaros mutants/product/Genecopoeia
    Average 94 stars, based on 1 article reviews
    pcdna3 ha ikaros mutants - by Bioz Stars, 2026-04
    94/100 stars
      Buy from Supplier

    94
    Genecopoeia pcdna3 ha ikaros wt
    Pcdna3 Ha Ikaros Wt, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pcdna3 ha ikaros wt/product/Genecopoeia
    Average 94 stars, based on 1 article reviews
    pcdna3 ha ikaros wt - by Bioz Stars, 2026-04
    94/100 stars
      Buy from Supplier

    99
    MedChemExpress pcdna3 1 ha ubiquitin
    Pcdna3 1 Ha Ubiquitin, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pcdna3 1 ha ubiquitin/product/MedChemExpress
    Average 99 stars, based on 1 article reviews
    pcdna3 1 ha ubiquitin - by Bioz Stars, 2026-04
    99/100 stars
      Buy from Supplier

    99
    Thermo Fisher pcdna3 1 ha hmgb1 wildtype dna
    Pcdna3 1 Ha Hmgb1 Wildtype Dna, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pcdna3 1 ha hmgb1 wildtype dna/product/Thermo Fisher
    Average 99 stars, based on 1 article reviews
    pcdna3 1 ha hmgb1 wildtype dna - by Bioz Stars, 2026-04
    99/100 stars
      Buy from Supplier

    90
    Addgene inc ha gsk3 beta wt pcdna3
    PKC regulates peroxisome – ER VAP-dependent interaction through GSK3b inhibition. (A) Quantification of confocal microscopy of peroxisomes stained with anti-PMP70 antibody in WT and VAPB/VAPA KO HeLa cells in control and GFP-VAPB overexpression conditions. Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100 cells pooled from three biological repeats, ***P < 0.001, ****P < 0.0001, Kruskal–Wallis test. (B) Confocal microscopy of peroxisomes stained with anti-PMP70 antibody in WT and VAPB/VAPA KO HeLa cells in control Go6983 (5 μM for 48 h). Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100, ***P < 0.001, ****P < 0.0001, one-way ANOVA. Western blot confirming the KO is shown. (C) Co-immunoprecipitation of mycACBD5 in control and PKC inhibition conditions (Go6983 5 μM, 24 h); mycACBD5 and GFP or GFP-VAPB were overexpressed in HEK293T cells. Quantification shows the IP to input ratio, mean ± SEM, N = 3, ***P < 0.001, ****P < 0.0001, one-way ANOVA. (D–F) Live cell confocal microscopy of ER and peroxisomes in U2OS cells in control and Go6983 conditions. Quantification shows the ratio of peroxisomes that are not proximal or overlapping with the ER, mean ± SEM, N = 6 pooled from 1,000 peroxisomes in at least 30 cells per condition, **P < 0.01, and a distance traveled by a single peroxisome in 30 s, mean ± SEM, N = 1,000, ****P < 0.0001, unpaired t test with Welch’s correction. (G) Co-immunoprecipitation of GFP-VAPB in control and PKCD-mCherry overexpression conditions in HEK293T cells overexpressing mycACBD5 and GFP-VAPB. Quantification shows the IP to input ratio, mean ± SEM, N = 4, ***P < 0.001, ****P < 0.0001, unpaired t test. (H) Western blot of GSK3β inhibitory S9 phosphorylation in PMA(0.5 μM for 2 h) and Go6983 (5 μM for 4 h) conditions. Quantification shows the ratio of phosphorylated pS9 GSK3β to non-phosphorylated GSK3β, mean ± SEM, N = 4, ***P < 0.001, **P < 0.01, one-way ANOVA. (I) Confocal microscopy of peroxisomes stained with anti-PMP70 antibody in HEK293T control or overexpression of GSK3β S9A mutant in control or PMA (0.5 μM for 4 h) conditions. (I) Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100 pooled from three biological repeats, ****P < 0.0001, Welch ANOVA. (J) Model of PKC regulation of peroxisome– ER interaction. Source data are available for this figure:  . OE, overexpressing; ns, nonsignificant; coIP, co-immunoprecipitation.
    Ha Gsk3 Beta Wt Pcdna3, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ha gsk3 beta wt pcdna3/product/Addgene inc
    Average 90 stars, based on 1 article reviews
    ha gsk3 beta wt pcdna3 - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    99
    Thermo Fisher n a recombinant dna pcdna3 1 thermofisher v79020 pcdna3 1 spdyawt ha
    PKC regulates peroxisome – ER VAP-dependent interaction through GSK3b inhibition. (A) Quantification of confocal microscopy of peroxisomes stained with anti-PMP70 antibody in WT and VAPB/VAPA KO HeLa cells in control and GFP-VAPB overexpression conditions. Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100 cells pooled from three biological repeats, ***P < 0.001, ****P < 0.0001, Kruskal–Wallis test. (B) Confocal microscopy of peroxisomes stained with anti-PMP70 antibody in WT and VAPB/VAPA KO HeLa cells in control Go6983 (5 μM for 48 h). Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100, ***P < 0.001, ****P < 0.0001, one-way ANOVA. Western blot confirming the KO is shown. (C) Co-immunoprecipitation of mycACBD5 in control and PKC inhibition conditions (Go6983 5 μM, 24 h); mycACBD5 and GFP or GFP-VAPB were overexpressed in HEK293T cells. Quantification shows the IP to input ratio, mean ± SEM, N = 3, ***P < 0.001, ****P < 0.0001, one-way ANOVA. (D–F) Live cell confocal microscopy of ER and peroxisomes in U2OS cells in control and Go6983 conditions. Quantification shows the ratio of peroxisomes that are not proximal or overlapping with the ER, mean ± SEM, N = 6 pooled from 1,000 peroxisomes in at least 30 cells per condition, **P < 0.01, and a distance traveled by a single peroxisome in 30 s, mean ± SEM, N = 1,000, ****P < 0.0001, unpaired t test with Welch’s correction. (G) Co-immunoprecipitation of GFP-VAPB in control and PKCD-mCherry overexpression conditions in HEK293T cells overexpressing mycACBD5 and GFP-VAPB. Quantification shows the IP to input ratio, mean ± SEM, N = 4, ***P < 0.001, ****P < 0.0001, unpaired t test. (H) Western blot of GSK3β inhibitory S9 phosphorylation in PMA(0.5 μM for 2 h) and Go6983 (5 μM for 4 h) conditions. Quantification shows the ratio of phosphorylated pS9 GSK3β to non-phosphorylated GSK3β, mean ± SEM, N = 4, ***P < 0.001, **P < 0.01, one-way ANOVA. (I) Confocal microscopy of peroxisomes stained with anti-PMP70 antibody in HEK293T control or overexpression of GSK3β S9A mutant in control or PMA (0.5 μM for 4 h) conditions. (I) Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100 pooled from three biological repeats, ****P < 0.0001, Welch ANOVA. (J) Model of PKC regulation of peroxisome– ER interaction. Source data are available for this figure:  . OE, overexpressing; ns, nonsignificant; coIP, co-immunoprecipitation.
    N A Recombinant Dna Pcdna3 1 Thermofisher V79020 Pcdna3 1 Spdyawt Ha, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/n a recombinant dna pcdna3 1 thermofisher v79020 pcdna3 1 spdyawt ha/product/Thermo Fisher
    Average 99 stars, based on 1 article reviews
    n a recombinant dna pcdna3 1 thermofisher v79020 pcdna3 1 spdyawt ha - by Bioz Stars, 2026-04
    99/100 stars
      Buy from Supplier

    90
    Addgene inc akt1 kinase-dead construct pcdna3-ha-akt1-k179m-t308a-s473a
    PKC regulates peroxisome – ER VAP-dependent interaction through GSK3b inhibition. (A) Quantification of confocal microscopy of peroxisomes stained with anti-PMP70 antibody in WT and VAPB/VAPA KO HeLa cells in control and GFP-VAPB overexpression conditions. Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100 cells pooled from three biological repeats, ***P < 0.001, ****P < 0.0001, Kruskal–Wallis test. (B) Confocal microscopy of peroxisomes stained with anti-PMP70 antibody in WT and VAPB/VAPA KO HeLa cells in control Go6983 (5 μM for 48 h). Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100, ***P < 0.001, ****P < 0.0001, one-way ANOVA. Western blot confirming the KO is shown. (C) Co-immunoprecipitation of mycACBD5 in control and PKC inhibition conditions (Go6983 5 μM, 24 h); mycACBD5 and GFP or GFP-VAPB were overexpressed in HEK293T cells. Quantification shows the IP to input ratio, mean ± SEM, N = 3, ***P < 0.001, ****P < 0.0001, one-way ANOVA. (D–F) Live cell confocal microscopy of ER and peroxisomes in U2OS cells in control and Go6983 conditions. Quantification shows the ratio of peroxisomes that are not proximal or overlapping with the ER, mean ± SEM, N = 6 pooled from 1,000 peroxisomes in at least 30 cells per condition, **P < 0.01, and a distance traveled by a single peroxisome in 30 s, mean ± SEM, N = 1,000, ****P < 0.0001, unpaired t test with Welch’s correction. (G) Co-immunoprecipitation of GFP-VAPB in control and PKCD-mCherry overexpression conditions in HEK293T cells overexpressing mycACBD5 and GFP-VAPB. Quantification shows the IP to input ratio, mean ± SEM, N = 4, ***P < 0.001, ****P < 0.0001, unpaired t test. (H) Western blot of GSK3β inhibitory S9 phosphorylation in PMA(0.5 μM for 2 h) and Go6983 (5 μM for 4 h) conditions. Quantification shows the ratio of phosphorylated pS9 GSK3β to non-phosphorylated GSK3β, mean ± SEM, N = 4, ***P < 0.001, **P < 0.01, one-way ANOVA. (I) Confocal microscopy of peroxisomes stained with anti-PMP70 antibody in HEK293T control or overexpression of GSK3β S9A mutant in control or PMA (0.5 μM for 4 h) conditions. (I) Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100 pooled from three biological repeats, ****P < 0.0001, Welch ANOVA. (J) Model of PKC regulation of peroxisome– ER interaction. Source data are available for this figure:  . OE, overexpressing; ns, nonsignificant; coIP, co-immunoprecipitation.
    Akt1 Kinase Dead Construct Pcdna3 Ha Akt1 K179m T308a S473a, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/akt1 kinase-dead construct pcdna3-ha-akt1-k179m-t308a-s473a/product/Addgene inc
    Average 90 stars, based on 1 article reviews
    akt1 kinase-dead construct pcdna3-ha-akt1-k179m-t308a-s473a - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    93
    Addgene inc ha egln1 pcdna3 ha phd2
    PKC regulates peroxisome – ER VAP-dependent interaction through GSK3b inhibition. (A) Quantification of confocal microscopy of peroxisomes stained with anti-PMP70 antibody in WT and VAPB/VAPA KO HeLa cells in control and GFP-VAPB overexpression conditions. Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100 cells pooled from three biological repeats, ***P < 0.001, ****P < 0.0001, Kruskal–Wallis test. (B) Confocal microscopy of peroxisomes stained with anti-PMP70 antibody in WT and VAPB/VAPA KO HeLa cells in control Go6983 (5 μM for 48 h). Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100, ***P < 0.001, ****P < 0.0001, one-way ANOVA. Western blot confirming the KO is shown. (C) Co-immunoprecipitation of mycACBD5 in control and PKC inhibition conditions (Go6983 5 μM, 24 h); mycACBD5 and GFP or GFP-VAPB were overexpressed in HEK293T cells. Quantification shows the IP to input ratio, mean ± SEM, N = 3, ***P < 0.001, ****P < 0.0001, one-way ANOVA. (D–F) Live cell confocal microscopy of ER and peroxisomes in U2OS cells in control and Go6983 conditions. Quantification shows the ratio of peroxisomes that are not proximal or overlapping with the ER, mean ± SEM, N = 6 pooled from 1,000 peroxisomes in at least 30 cells per condition, **P < 0.01, and a distance traveled by a single peroxisome in 30 s, mean ± SEM, N = 1,000, ****P < 0.0001, unpaired t test with Welch’s correction. (G) Co-immunoprecipitation of GFP-VAPB in control and PKCD-mCherry overexpression conditions in HEK293T cells overexpressing mycACBD5 and GFP-VAPB. Quantification shows the IP to input ratio, mean ± SEM, N = 4, ***P < 0.001, ****P < 0.0001, unpaired t test. (H) Western blot of GSK3β inhibitory S9 phosphorylation in PMA(0.5 μM for 2 h) and Go6983 (5 μM for 4 h) conditions. Quantification shows the ratio of phosphorylated pS9 GSK3β to non-phosphorylated GSK3β, mean ± SEM, N = 4, ***P < 0.001, **P < 0.01, one-way ANOVA. (I) Confocal microscopy of peroxisomes stained with anti-PMP70 antibody in HEK293T control or overexpression of GSK3β S9A mutant in control or PMA (0.5 μM for 4 h) conditions. (I) Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100 pooled from three biological repeats, ****P < 0.0001, Welch ANOVA. (J) Model of PKC regulation of peroxisome– ER interaction. Source data are available for this figure:  . OE, overexpressing; ns, nonsignificant; coIP, co-immunoprecipitation.
    Ha Egln1 Pcdna3 Ha Phd2, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ha egln1 pcdna3 ha phd2/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    ha egln1 pcdna3 ha phd2 - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    Image Search Results


    PKC regulates peroxisome – ER VAP-dependent interaction through GSK3b inhibition. (A) Quantification of confocal microscopy of peroxisomes stained with anti-PMP70 antibody in WT and VAPB/VAPA KO HeLa cells in control and GFP-VAPB overexpression conditions. Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100 cells pooled from three biological repeats, ***P < 0.001, ****P < 0.0001, Kruskal–Wallis test. (B) Confocal microscopy of peroxisomes stained with anti-PMP70 antibody in WT and VAPB/VAPA KO HeLa cells in control Go6983 (5 μM for 48 h). Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100, ***P < 0.001, ****P < 0.0001, one-way ANOVA. Western blot confirming the KO is shown. (C) Co-immunoprecipitation of mycACBD5 in control and PKC inhibition conditions (Go6983 5 μM, 24 h); mycACBD5 and GFP or GFP-VAPB were overexpressed in HEK293T cells. Quantification shows the IP to input ratio, mean ± SEM, N = 3, ***P < 0.001, ****P < 0.0001, one-way ANOVA. (D–F) Live cell confocal microscopy of ER and peroxisomes in U2OS cells in control and Go6983 conditions. Quantification shows the ratio of peroxisomes that are not proximal or overlapping with the ER, mean ± SEM, N = 6 pooled from 1,000 peroxisomes in at least 30 cells per condition, **P < 0.01, and a distance traveled by a single peroxisome in 30 s, mean ± SEM, N = 1,000, ****P < 0.0001, unpaired t test with Welch’s correction. (G) Co-immunoprecipitation of GFP-VAPB in control and PKCD-mCherry overexpression conditions in HEK293T cells overexpressing mycACBD5 and GFP-VAPB. Quantification shows the IP to input ratio, mean ± SEM, N = 4, ***P < 0.001, ****P < 0.0001, unpaired t test. (H) Western blot of GSK3β inhibitory S9 phosphorylation in PMA(0.5 μM for 2 h) and Go6983 (5 μM for 4 h) conditions. Quantification shows the ratio of phosphorylated pS9 GSK3β to non-phosphorylated GSK3β, mean ± SEM, N = 4, ***P < 0.001, **P < 0.01, one-way ANOVA. (I) Confocal microscopy of peroxisomes stained with anti-PMP70 antibody in HEK293T control or overexpression of GSK3β S9A mutant in control or PMA (0.5 μM for 4 h) conditions. (I) Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100 pooled from three biological repeats, ****P < 0.0001, Welch ANOVA. (J) Model of PKC regulation of peroxisome– ER interaction. Source data are available for this figure:  . OE, overexpressing; ns, nonsignificant; coIP, co-immunoprecipitation.

    Journal: The Journal of Cell Biology

    Article Title: Protein Kinase C promotes peroxisome biogenesis and peroxisome–endoplasmic reticulum interaction

    doi: 10.1083/jcb.202505040

    Figure Lengend Snippet: PKC regulates peroxisome – ER VAP-dependent interaction through GSK3b inhibition. (A) Quantification of confocal microscopy of peroxisomes stained with anti-PMP70 antibody in WT and VAPB/VAPA KO HeLa cells in control and GFP-VAPB overexpression conditions. Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100 cells pooled from three biological repeats, ***P < 0.001, ****P < 0.0001, Kruskal–Wallis test. (B) Confocal microscopy of peroxisomes stained with anti-PMP70 antibody in WT and VAPB/VAPA KO HeLa cells in control Go6983 (5 μM for 48 h). Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100, ***P < 0.001, ****P < 0.0001, one-way ANOVA. Western blot confirming the KO is shown. (C) Co-immunoprecipitation of mycACBD5 in control and PKC inhibition conditions (Go6983 5 μM, 24 h); mycACBD5 and GFP or GFP-VAPB were overexpressed in HEK293T cells. Quantification shows the IP to input ratio, mean ± SEM, N = 3, ***P < 0.001, ****P < 0.0001, one-way ANOVA. (D–F) Live cell confocal microscopy of ER and peroxisomes in U2OS cells in control and Go6983 conditions. Quantification shows the ratio of peroxisomes that are not proximal or overlapping with the ER, mean ± SEM, N = 6 pooled from 1,000 peroxisomes in at least 30 cells per condition, **P < 0.01, and a distance traveled by a single peroxisome in 30 s, mean ± SEM, N = 1,000, ****P < 0.0001, unpaired t test with Welch’s correction. (G) Co-immunoprecipitation of GFP-VAPB in control and PKCD-mCherry overexpression conditions in HEK293T cells overexpressing mycACBD5 and GFP-VAPB. Quantification shows the IP to input ratio, mean ± SEM, N = 4, ***P < 0.001, ****P < 0.0001, unpaired t test. (H) Western blot of GSK3β inhibitory S9 phosphorylation in PMA(0.5 μM for 2 h) and Go6983 (5 μM for 4 h) conditions. Quantification shows the ratio of phosphorylated pS9 GSK3β to non-phosphorylated GSK3β, mean ± SEM, N = 4, ***P < 0.001, **P < 0.01, one-way ANOVA. (I) Confocal microscopy of peroxisomes stained with anti-PMP70 antibody in HEK293T control or overexpression of GSK3β S9A mutant in control or PMA (0.5 μM for 4 h) conditions. (I) Quantification shows the number of peroxisomes per micron square, mean ± SEM, N = 100 pooled from three biological repeats, ****P < 0.0001, Welch ANOVA. (J) Model of PKC regulation of peroxisome– ER interaction. Source data are available for this figure: . OE, overexpressing; ns, nonsignificant; coIP, co-immunoprecipitation.

    Article Snippet: HA GSK3 beta WT pcDNA3 was a gift from Jim Woodgett (National Institutes of Health, Bethesda, MD, USA; plasmid #14753; Addgene; https://n2t.net/addgene:14753 ; RRID:Addgene_14753) ( ). pCDNA3.1-PPARA was a gift from Claes Wadelius (Uppsala University, Uppsala, Sweden; plasmid #169019; Addgene; https://n2t.net/addgene:169019 ; RRID:Addgene_169019) ( ).

    Techniques: Inhibition, Confocal Microscopy, Staining, Control, Over Expression, Western Blot, Immunoprecipitation, Phospho-proteomics, Mutagenesis